CN Patent
CN110330540A — 核苷盐及其制备方法
Assigned to Mutian (jinan) Biotechnology Co Ltd · Expires 2019-10-15 · 7y expired
What this patent protects
本发明涉及化学合成领域,尤其涉及式(III)或式(IV)所示的核苷盐及其制备方法。本发明提供的方法操作简单,路线简洁,收率较高,所用的试剂均为常用试剂,在实验室中可方便实现10‑100克级的制备,可适合大规模制备。
USPTO Abstract
本发明涉及化学合成领域,尤其涉及式(III)或式(IV)所示的核苷盐及其制备方法。本发明提供的方法操作简单,路线简洁,收率较高,所用的试剂均为常用试剂,在实验室中可方便实现10‑100克级的制备,可适合大规模制备。
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.